BITGF
Price
$14.80
Change
-$1.20 (-7.50%)
Updated
Nov 6 closing price
VRCDF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 3 closing price
Ad is loading...

BITGF vs VRCDF

Header iconBITGF vs VRCDF Comparison
Open Charts BITGF vs VRCDFBanner chart's image
Biotage AB
Price$14.80
Change-$1.20 (-7.50%)
Volume$400
CapitalizationN/A
VERICI DX
Price$0.03
Change-$0.00 (-0.00%)
Volume$300
CapitalizationN/A
BITGF vs VRCDF Comparison Chart
Loading...
View a ticker or compare two or three
VS
BITGF vs. VRCDF commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BITGF is a Hold and VRCDF is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (BITGF: $14.80 vs. VRCDF: $0.03)
Brand notoriety: BITGF and VRCDF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BITGF: 136% vs. VRCDF: 3%
Market capitalization -- BITGF: $984.11M vs. VRCDF: $22.99M
BITGF [@Medical Specialties] is valued at $984.11M. VRCDF’s [@Medical Specialties] market capitalization is $22.99M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BITGF’s FA Score shows that 1 FA rating(s) are green whileVRCDF’s FA Score has 1 green FA rating(s).

  • BITGF’s FA Score: 1 green, 4 red.
  • VRCDF’s FA Score: 1 green, 4 red.
According to our system of comparison, BITGF is a better buy in the long-term than VRCDF.

Price Growth

BITGF (@Medical Specialties) experienced а 0.00% price change this week, while VRCDF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.08%. For the same industry, the average monthly price growth was +3.94%, and the average quarterly price growth was +5.39%.

Industries' Descriptions

@Medical Specialties (-2.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
BITGF($984M) has a higher market cap than VRCDF($23M). BITGF YTD gains are higher at: 23.333 vs. VRCDF (-72.727). BITGF has higher annual earnings (EBITDA): 378M vs. VRCDF (-10.35M). BITGF has more cash in the bank: 444M vs. VRCDF (15.7M). VRCDF has less debt than BITGF: VRCDF (0) vs BITGF (374M). BITGF has higher revenues than VRCDF: BITGF (1.55B) vs VRCDF (0).
BITGFVRCDFBITGF / VRCDF
Capitalization984M23M4,278%
EBITDA378M-10.35M-3,653%
Gain YTD23.333-72.727-32%
P/E Ratio33.90N/A-
Revenue1.55B0-
Total Cash444M15.7M2,828%
Total Debt374M0-
FUNDAMENTALS RATINGS
BITGF: Fundamental Ratings
BITGF
OUTLOOK RATING
1..100
45
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
81
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

BITGF and

Correlation & Price change

A.I.dvisor tells us that BITGF and TMCI have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BITGF and TMCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BITGF
1D Price
Change %
BITGF100%
N/A
TMCI - BITGF
22%
Poorly correlated
-1.78%
VRCDF - BITGF
21%
Poorly correlated
N/A
GCTK - BITGF
21%
Poorly correlated
-3.77%
CHEOF - BITGF
5%
Poorly correlated
N/A
BMXMF - BITGF
2%
Poorly correlated
N/A
More

VRCDF and

Correlation & Price change

A.I.dvisor tells us that VRCDF and AVNS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRCDF and AVNS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRCDF
1D Price
Change %
VRCDF100%
N/A
AVNS - VRCDF
32%
Poorly correlated
-4.11%
TNON - VRCDF
25%
Poorly correlated
-1.55%
BITGF - VRCDF
21%
Poorly correlated
N/A
ANPCY - VRCDF
21%
Poorly correlated
N/A
ITGDF - VRCDF
4%
Poorly correlated
N/A
More